| Term 
 
        | vitamin B12 is called . . . |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | a set of biochemical reactions that produce deoxythymidylate (dTMP), an essential constituent of DNA synthesis   Cycle depends on convesion of dihyrdofolate to tetrahydrofolate by dihydrofolate reductase |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | granulocyte colongy-stimulating factor, a hematopoietic growth factor that regulates production and fnx of neutrophils |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | granulocyte-macrophage colongy-stimulating factor, a hematopoietic growth factor that regulates production of granulocytes (basophils, eosinophils, and neutrophils) and other myeloid cells |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | a condition of chronic excess total body iron cused by either an inherited abnormality of iron absorption or by frequent transfusion to treat certain types of hemolytic disorders (ex: thalassemia major) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | deficiency in serum hemoglobin and erythrocytes in which the erythrocytes are abnormally large. Results from either folate or vitamin B12 deficiency anemia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | deficiency in serum hemoglobin and erythrocytes in which the erythrocytes are abnormally small   often caused by iron deficiency |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | abnormally low number of neutrophils in the blood; pateints with neutropenia are susceptible to serious infection |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | form of megaloblastic anemia resulting from deficiency of inrinsic factor, a protein produced by gastric mucosal cells and required for intestinal absorption of vitamin B12 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | abnormally low number of platelets in blood = they are susceptible to hemorrhage |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1) essential part of the heme molecule 2) an important fraction of iron boud to transferrin (transport protein) and ferritin (storage protein) |  | 
        |  | 
        
        | Term 
 
        | most of the iron deficiency in ... |  | Definition 
 
        | women - due to menstrual blood loss   vegetariansand malnourished persons = inadequate Fe intake   Children and pregnant women have increased iron demands |  | 
        |  | 
        
        | Term 
 
        | Regulation of iron stores ... absorption or excretion? |  | Definition 
 
        | no mechanisms for excretion, so regulation of body iron is via intestinal absorption |  | 
        |  | 
        
        | Term 
 
        | absorption of iron - In which form: ferrous or ferric |  | Definition 
 
        | heme is in the form of the Ferrous ion (Fe2+) - taken up by specialized divalent metal transporter 1 (DMT1) in intestinal epithelial cells   cells store iron as either ferritin or transport the ferrous ion across basolateral by ferroportin   then it is oxizided to Ferric iron (Fe3+) by ferroxidase |  | 
        |  | 
        
        | Term 
 
        | Transport and storage of iron |  | Definition 
 
        | ferric iron is transported in complex with transferrin 
 excess iron is stored in the protein bound form in: 
GI epithelial cellsmacrophagesheptocytesparenchymal cells of skin, heart, and other organs (but that is in cases of great overload) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | minimal amounts of iron are lost from body with sweat and saliva and in exfoliated skin and intestinal mucosal cells |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | prevention or treatment of iron deficiency anemia is only indication for iron administration   iron supplementation with ferrous sulfate, ferrous gluconate, or ferrous fumarate   special case you treat with IV admin of a colloid containing a core of iron oxyhydroxide surrounded by a core of carbohydrate   IV preps include: 
iron dextransodium ferric gluconate complexiron sucrose |  | 
        |  | 
        
        | Term 
 
        | When would you NOT give iron? |  | Definition 
 
        | in hemolytic anemia - iron stores are already elevated in this type of anemia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | acute iron intoxication is most common in children (by eating iron tablets)   
necrotizing gastroenteritisshockmetabolic acidosiscomadeath chronic iron overload (ie hemochromatosis) damages the organs that store excess iron (heart, liver, pancreas) |  | 
        |  | 
        
        | Term 
 
        | treatment of acute and chronic iron toxicity |  | Definition 
 
        | acute: immediate tx needed = removal of unabsorbed tablets from the gut; correct acid-base and enlectrolyte abnormalities; parentral admin of deferoxamine (chelates!!)   chronic: phlebotomy for genetic form; if due to infusions, chronically admin a chelator such as deferoxamine or deferasirox |  | 
        |  | 
        
        | Term 
 
        | name two iron chelators and when are they used? |  | Definition 
 
        | deferoxamine (acute and chronic iron toxicity)   deferasirox (chronic iron toxicity) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | it is a cobalt-containing molecule   along with folic acid, is a cofactor for transfer of 1-carbon units, a step necessary for the synthesis of DNA (which manifests first as anemia because RBCs are constantly being produced) |  | 
        |  | 
        
        | Term 
 
        | B12 is absorbed (stomach and plasma transport). . . |  | Definition 
 
        | from GI tract in presence of intrinsic factor (product of parietal cells of stomach)   plasma transport = binding to transcobalamin II   stored in large amounts in liver (enough to last 5 yrs) |  | 
        |  | 
        
        | Term 
 
        | what are the 2 available forms of vitamin B12 and what is the difference between them? |  | Definition 
 
        | cyanocobalamin and hydroxocobalamin   have similar pharmacokinetics, but later has longer circulating half-life |  | 
        |  | 
        
        | Term 
 
        | pharmacodynamics of vitamin B12 |  | Definition 
 
        | B12 essential in 2 reactions: 1) conversion of methylmalonyl coenzyme A (CoA) to succinyl-CoA 2) conversion of homocysteine to methionine   rxn #2 related to folic acid metabolism and synthesis of deoxythymidylate (dTMP) --> precursor for DNA synthesis |  | 
        |  | 
        
        | Term 
 
        | clinical use and toxicity of B12 |  | Definition 
 
        | 2 forms available: hydroxocobalamin and cyanocobalamin   they have equivalent effects   tx of naturally occurring ernicious anemia and anemia caused by gastric resection   use parenteral therapy   no significant toxicity |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | role: required for normal DNA synthesis; defeciency = megaloblastic anemia; neural tube defects during pregnancy   pharmacokinetics: readily absorbed from GI tract; only modest amounts stored in body (so anemia is within months of depleted levels)   pharmacodynamics: converted to tetrahydrofolate by action of dihyrdofolate reductase; important for dTMP cycle = suplies dTMP required for DNA synthesis, so rapidly dividing cells, like RBCs are most often involved --> this is why antifolate drugs are useful in tx of various infections and cancers   Clinical use and tox: most often b/c dietary insufficiency or malabsorption - anemia is readily treated by folic acid supplementation   Remember folic acid BEFORE and during pregnancy (but doesn't correct NT defects) |  | 
        |  | 
        
        | Term 
 
        | erythropoietin and what is the name of the recombinant human EPO   toxicity of EPO |  | Definition 
 
        | normally produced by kidney (so depletion of this = anemia of renal failure)   recombinant human erythropoietin = epoetin alfa --> used for anemia associated with renal failure, but effective in other patients (HIV, cancer patients)   acute tox is minimal, but if increase Hct excessively = risk of thrombosis and cardiovacular events |  | 
        |  | 
        
        | Term 
 
        | name other forms of EPO and what is unique about them? |  | Definition 
 
        | Darbepoeitn alfa = glycosylated form of EPO = much longer half-life   Methoxy polyethylene glycol-epoetin beta = long-lasting form of erythropoietin that can be administered once or twice a month |  | 
        |  | 
        
        | Term 
 
        | complications of EPO therapy |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | filgrastim (granulocyte colony-stimulating factor; G-CSF)   sargramostim (granulocyte-macrophage colony-stimulating factor; GM-CSF)   used to acclerate recovery of neutrophils after cancer chemotherapy |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | production of neutrophils; also stimulates production of other myeloid and megakaryocytes progenitors   can mobilize hematopoietic stem cells (but to a lesser degree G-CSF)   more severe side effects: fever, arthralgias, and capillary damage with edema (allergic reactions are rare) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | for neutrophils and can mobilitze hemopeotic stem cells   toxicity is minimal, but can cause bone pain |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | covalent conjugation product of filgrastim and a form of polyethylene glycol   much longer half-life |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | interleukin-11   stimulates growth of primitive megakaryocytic progenitors and increases the number of peripheral platelets   tx for thrombocytopenia after a cycle of cancer chemotherapy   tox/side effects: fatigue, headache, dizziness, fluid retention |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | novel megakaryocyte GF that depends on a peptide selected from a peptide library on the basis of thrombopoietin receptor activation   linked to polyglycine sequence to human Fc = stable half life (3-4 days)   approved for tx of patients with chronic idiopathic thrombocytopenia who have failed to respond to conventional tx |  | 
        |  | 
        
        | Term 
 
        | what is the treatment choice for pernicious anemia |  | Definition 
 
        | hydroxocobalamin injection |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | - absorption of B12 via intrinsic factor - all formed elements of blood are affected - if due to vit B12 deficiency, it does NOT develop readily - high oral doses of B12 can be used in patients who refuse IM injections - alcoholics may be at risk due to FOLIC ACID deficiency |  | 
        |  | 
        
        | Term 
 
        | hypochromic microcytic anemia |  | Definition 
 
        | takes long time to replace the iron stores!!! |  | 
        |  | 
        
        | Term 
 
        | agent of choice for treating iron poisoning in a child is |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | - it's megaloblastic anemia is microscopically indistinguishable from that caused by B12 deficiency - unlike B12 deficiency, in folic acid deficiency is caused by inadequate diet - phenytoin and some other anticonvulsants can interfere with folic acid absorption - neurologic syndrome produced by B12 deficiency can NOT be treated with folic acid |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | patients with anemia due to chronic renal failure do NOT have high serum EPO levels   - daropoetin alfa has longer half life than epoetin alfa   - adverse effects of epoetin alfa include htn and thrombotic complications   -failure to respond to EPO is commonly due to Fe deficiency   - Epoetin alpha can be used to offset the anemia produced by zidovudine tx in patients wiht HIV infection |  | 
        |  | 
        
        | Term 
 
        | statements about meyloid growth factors |  | Definition 
 
        | - filgrastim is generally reserved for patients with a prior episode of febrile neutropenia after cytotoxic chemotherapy or those at high risk for febrile neutropenia   - advantage of pegfilgrastim compared to filgrastim = admin less frequently |  | 
        |  | 
        
        | Term 
 
        | which of the two has more severe side effects: sargramostim or filgrastim? |  | Definition 
 
        | sargramostim   both are NOT contraindicated in patients with AML |  | 
        |  | 
        
        | Term 
 
        | which is more efficatious in mobilizing peripheral blood stem cells for autologous and allogenic hematopoietic stem cell transplantation: sargramostim or filgrastim? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what are common side effects of oprelvekin |  | Definition 
 
        | headache, fatigue, and dizziness |  | 
        |  | 
        
        | Term 
 
        | what effects does oprelvekin have on leukopenia or neutropenia caused by myelosuppressive therapy? |  | Definition 
 
        | it has little effect on leukopenia and neutroopenia |  | 
        |  | 
        
        | Term 
 
        | how is oprelvekin administered (typically)? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | is oprelvekin a recombinant form of thrombopoietin? |  | Definition 
 
        | No it is not recombinant form! |  | 
        |  |